What's with the 4DMedical (ASX:4DX) share price today?

The 4DMedical (ASX: 4DX) share price has dipped early this afternoon after 2 major announcements from the company. Let's take a look.

The 4DMedical Ltd (ASX: 4DX) share price shot up 4.6% in opening today before falling into the red early this afternoon. This, after the medical technology company announced it had received a government grant and would begin a capital raising program.

The 4DMedical share price opened at $1.81, up 8 cents on yesterday's close but has since retreated to $1.73, putting it flat at the time of writing.

Shares in the company were placed in voluntary suspension for 2 days earlier this week, in anticipation of the news.

Woman in mustard yellow blouse on laptop holds both hands out to either side with graphic illustration of question marks above them

Image source: Getty Images

Why is the 4D Medical share price moving today?

In today's release, the company announced a consortium led by 4DMedical, the Australian Lung Health Initiative (ALHI), has been awarded a $28.9 million federal government grant.  The company said the cash will be used to develop "the world's first" lung function scanners to provide "safe, easy and rapid lung analysis" for both adults and children.

The grant is a part of the Federal Government's Medical Research Future Fund (MRFF) – a $20 billion program aiming to "transform health and medical research". The government will allocate the funding over a 5-year period.

4DMedical has exclusive commercial rights for the XVD Scanners – including intellectual property rights. The medical technology company will receive 100% of the revenue from scanner sales.

In conjunction with the grant, 4DMedical will also complete a $40 million capital raising project. It will list 25.8 million new shares on the ASX at a price of $1.55 each. Existing shareholders will be able to apply for these shares, too. The cap for new shares for existing shareholders is a $30,000 value.

The company expects trading of new shares to begin 15 March. The issuance will occur on 7 April.

Words from the CEO

Commenting on the MRFF funding, 4DMedical founder and CEO, Andreas Fouras, said:

We're thrilled with the huge vote of confidence afforded by the competitive assessment process, as we aim to deliver safe and accurate lung health technology to those who need it. I thank our partners on this project for their outstanding support as we look forward to bringing this Australian innovation to fruition.

[The capital raising initiative] will provide us with the funds needed to execute the long-term commercialisation strategy for XVD Scanners, which will open up an additional revenue stream for the business…

…[It] also provides us with balance sheet flexibility for future growth opportunities that can accelerate the commercialisation of the XV LVAS product…

The company estimates the lung diagnostics market at $40 billion a year.

4DMedical share price snapshot

This time last year, the 4DMedical share price was swapping hands at $1.59. At today's price that calculates at 8.49% growth. However, the 4DMedical share price has been trending downwards for the year-to-date. The share price in the new year was $2.44 – representing a 29.3% fall.

4DMedical's market capitalisation is $307 million.

Motley Fool contributor Marc Sidarous has no position in any of the shares mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »

Army man holding a drone while the army woman holds the remote control.
52-Week Lows

Can DroneShield shares rebound from fresh 52-week low, or is there more downside ahead?

Investors have fallen out of love with the counter-drone operator’s shares.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Frustrated man looking exhausted while sitting at his desk with his laptop and carrying his glasses in his hand.
ASX Share Market News

5 things to watch on the ASX 200 on Tuesday

It looks set to be a tough session for Aussie investors.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

Man with his hands out as if pondering his options.
Opinions

I've always loved Wesfarmers shares. But after a trip to Kmart, I'm not so sure

A weekend trip took some gloss off this stock.

Read more »